Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
91-105 of 2220 results
Oxford BioMedica secures UK MHRA approval to manufacture drugs at new facilities
By PBR Staff Writer
Oxford BioMedica has secured approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for investigational medicinal products at its new facilities.
Production & Manufacturing > Manufacturing > News
GSK to invest £275m in three UK manufacturing sites
By PBR Staff Writer
GlaxoSmithKline (GSK) has unveiled plans to invest £275m in its UK manufacturing network, and said that it views the country as an attractive location for investment despite last month's vote to leave the European Union.
Production & Manufacturing > Manufacturing > News
Shangai Fosun to buy 86% stake in Gland Pharma for $1.26bn
By PBR Staff Writer
China's Shangai Fosun Pharmaceutical has agreed to acquire about 86% stake in Indian drugmaker Gland Pharma for $1.26bn.
Production & Manufacturing > Manufacturing > News
Hemispherx signs deal with Avrio Biopharmaceuticals for accelerated production of Ampligen
Hemispherx Biopharma has reached an agreement with Avrio Biopharmaceuticals ("Avrio"), Irvine California, to serve as an additional contract manufacturer of Hemispherx's experimental drug, Ampligen, also known by its generic name rintatolimod.
Production & Manufacturing > Manufacturing > News
Vectura initiates legal proceedings against GlaxoSmithKline
Vectura Group has received formal notification from GlaxoSmithKline ('GSK') that GSK does not wish to exercise the option to take a license to any additional patents under the patent licence and option agreement with Vectura dated 5th August 2010 for GSK's Breo Ellipta/Relvar Ellipta, Anoro Ellipta and Incruse Ellipta products (the Ellipta products).
Production & Manufacturing > Manufacturing > News
US FTC approves Teva’s $40.5bn deal for Allergan’s generics business
By PBR Staff Writer
The US Federal Trade Commission (FTC) has approved Teva Pharmaceutical Industries’ proposed $40.5bn acquisition of Allergan’s generics business.
Production & Manufacturing > Manufacturing > News
Just Biotherapeutics secures $14M series A2 funding
Just Biotherapeutics, an organization dedicated to expanding global access to important protein therapeutics, announced the closing of a $14M Series A2 financing round.
Production & Manufacturing > Manufacturing > News
Scancell appoints Eurogentec SCIB1 material manufacturer
Scancell has signed an agreement with Eurogentec for the manufacture of new supplies of Scancell’s SCIB1 ImmunoBody vaccine for use in the US clinical study of SCIB1 in combination with a checkpoint inhibitor, expected to commence in 2017.
Production & Manufacturing > Manufacturing > News
Shire acquires stake in Chronos Therapeutics
By PBR Staff Writer
Shire has acquired a stake in Chronos Therapeutics, a UK-based privately held biotechnology company focused on diseases of ageing, brain and nervous system disorders.
Production & Manufacturing > Manufacturing > News
MilliporeSigma starts work on $115m life science campus in Massachusetts
By PBR Staff Writer
MilliporeSigma has started construction on a $115m multi-faceted life science campus in Burlington, Massachusetts, US.
Production & Manufacturing > Manufacturing > News
AstraZeneca, Sandoz resolve Faslodex patent litigation in US
By PBR Staff Writer
AstraZeneca has signed an agreement with Sandoz, the generic pharmaceuticals division of Novartis, to resolve Faslodex (fulvestrant) patent litigation in the US.
Production & Manufacturing > Manufacturing > News
Funds advised by Apax Partners agree to buy operating subsidiaries of Invent Farm
By PBR Staff Writer
Funds advised by Apax Partners have agreed to acquire the operating subsidiaries of Spanish pharmaceutical firm Invent Farm from a consortium of investors led by Silfurberg, Framtakssjóður Íslands and Horn II.
Production & Manufacturing > Manufacturing > News
Teligent advances $50m facility expansion in Buena
Teligent has broken ground on the ongoing expansion of its manufacturing and research and development complex in Buena, NJ.
Production & Manufacturing > Manufacturing > News
Aprecia Pharmaceuticals signs $30m debt financing agreement with Hercules Capital
Aprecia Pharmaceuticals, a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, has entered into an up to $30m debt financing agreement with Hercules Capital.
Production & Manufacturing > Manufacturing > News
AstraZeneca divests two dermatology drug rights to LEO Pharma
By PBR Staff Writer
AstraZeneca has sold the rights to develop tralokinumab drug to treat atopic dermatitis to LEO Pharma.
Production & Manufacturing > Manufacturing > News
91-105 of 2220 results